Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NOW vs GSK✓SelectedUSD · GSKNOW vs GSK performance historyLatest closeAs of-2.82%11/16
Stock and ETF performance explorer

NOW vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-40.6%
GSK return
+9.7%
Excess return
-50.2%
Maximum drawdown
-52.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.8%-0.1%-2.7%-2.8%
7D-3.3%-1.3%-2.0%-3.4%
30D-30.0%+2.7%-32.7%-29.7%
3M-19.9%+2.7%-22.6%-19.7%
6M+4.5%+3.3%+1.2%+5.8%
YTD-35.1%+6.5%-41.6%-38.8%
All-40.6%+9.7%-50.2%-43.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling